Cargando…
Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia
The root microbiome of medical cannabis plants has been largely unexplored due to past legal restrictions in many countries. Microbes that live on and within the tissue of Cannabis sativa L. similar to other plants, provide advantages such as stimulating plant growth, helping it absorb minerals, pro...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502174/ https://www.ncbi.nlm.nih.gov/pubmed/37719209 http://dx.doi.org/10.3389/fpls.2023.1219836 |
_version_ | 1785106264936677376 |
---|---|
author | Ahmed, Bulbul Beneš, František Hajšlová, Jana Fišarová, Lenka Vosátka, Miroslav Hijri, Mohamed |
author_facet | Ahmed, Bulbul Beneš, František Hajšlová, Jana Fišarová, Lenka Vosátka, Miroslav Hijri, Mohamed |
author_sort | Ahmed, Bulbul |
collection | PubMed |
description | The root microbiome of medical cannabis plants has been largely unexplored due to past legal restrictions in many countries. Microbes that live on and within the tissue of Cannabis sativa L. similar to other plants, provide advantages such as stimulating plant growth, helping it absorb minerals, providing protection against pathogen attacks, and influencing the production of secondary metabolites. To gain insight into the microbial communities of C. sativa cultivars with different tetrahydrocannabinol (THC) and cannabidiol (CBD) profiles, a greenhouse trial was carried out with and without inoculants added to the growth substrate. Illumina MiSeq metabarcoding was used to analyze the root and rhizosphere microbiomes of the five cultivars. Plant biomass production showed higher levels in three of five cultivars inoculated with the arbuscular mycorrhizal fungus Rhizophagus irregularis and microbial suspension. The blossom dry weight of the cultivar THE was greater when inoculated with R. irregularis and microbial suspension than with no inoculation. Increasing plant biomass and blossom dry weight are two important parameters for producing cannabis for medical applications. In mature Cannabis, 12 phytocannabinoid compounds varied among cultivars and were affected by inoculants. Significant differences (p ≤ 0.01) in concentrations of cannabidivarinic acid (CBDVA), cannabidivarin (CBDV), cannabigerol (CBG), cannabidiol (CBD), and cannabigerolic acid (CBGA) were observed in all Cannabis cultivars when amended with F, K1, and K2 inoculants. We found microbes that were shared among cultivars. For example, Terrimicrobium sp., Actinoplanes sp., and Trichoderma reesei were shared by the cultivars ECC-EUS-THE, CCL-ECC, and EUS-THE, respectively. Actinoplanes sp. is a known species that produces phosphatase enzymes, while Trichoderma reesei is a fungal train that produces cellulase and contributes to organic matter mineralization. However, the role of Terrimicrobium sp. as an anaerobic bacterium remains unknown. This study demonstrated that the use of inoculants had an impact on the production of phytocannabinoids in five Cannabis cultivars. These inoculants could have useful applications for optimizing cannabis cultivation practices and increasing the production of phytocannabinoids. |
format | Online Article Text |
id | pubmed-10502174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105021742023-09-16 Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia Ahmed, Bulbul Beneš, František Hajšlová, Jana Fišarová, Lenka Vosátka, Miroslav Hijri, Mohamed Front Plant Sci Plant Science The root microbiome of medical cannabis plants has been largely unexplored due to past legal restrictions in many countries. Microbes that live on and within the tissue of Cannabis sativa L. similar to other plants, provide advantages such as stimulating plant growth, helping it absorb minerals, providing protection against pathogen attacks, and influencing the production of secondary metabolites. To gain insight into the microbial communities of C. sativa cultivars with different tetrahydrocannabinol (THC) and cannabidiol (CBD) profiles, a greenhouse trial was carried out with and without inoculants added to the growth substrate. Illumina MiSeq metabarcoding was used to analyze the root and rhizosphere microbiomes of the five cultivars. Plant biomass production showed higher levels in three of five cultivars inoculated with the arbuscular mycorrhizal fungus Rhizophagus irregularis and microbial suspension. The blossom dry weight of the cultivar THE was greater when inoculated with R. irregularis and microbial suspension than with no inoculation. Increasing plant biomass and blossom dry weight are two important parameters for producing cannabis for medical applications. In mature Cannabis, 12 phytocannabinoid compounds varied among cultivars and were affected by inoculants. Significant differences (p ≤ 0.01) in concentrations of cannabidivarinic acid (CBDVA), cannabidivarin (CBDV), cannabigerol (CBG), cannabidiol (CBD), and cannabigerolic acid (CBGA) were observed in all Cannabis cultivars when amended with F, K1, and K2 inoculants. We found microbes that were shared among cultivars. For example, Terrimicrobium sp., Actinoplanes sp., and Trichoderma reesei were shared by the cultivars ECC-EUS-THE, CCL-ECC, and EUS-THE, respectively. Actinoplanes sp. is a known species that produces phosphatase enzymes, while Trichoderma reesei is a fungal train that produces cellulase and contributes to organic matter mineralization. However, the role of Terrimicrobium sp. as an anaerobic bacterium remains unknown. This study demonstrated that the use of inoculants had an impact on the production of phytocannabinoids in five Cannabis cultivars. These inoculants could have useful applications for optimizing cannabis cultivation practices and increasing the production of phytocannabinoids. Frontiers Media S.A. 2023-08-31 /pmc/articles/PMC10502174/ /pubmed/37719209 http://dx.doi.org/10.3389/fpls.2023.1219836 Text en Copyright © 2023 Ahmed, Beneš, Hajšlová, Fišarová, Vosátka and Hijri https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Plant Science Ahmed, Bulbul Beneš, František Hajšlová, Jana Fišarová, Lenka Vosátka, Miroslav Hijri, Mohamed Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia |
title | Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia |
title_full | Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia |
title_fullStr | Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia |
title_full_unstemmed | Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia |
title_short | Enhanced production of select phytocannabinoids in medical Cannabis cultivars using microbial consortia |
title_sort | enhanced production of select phytocannabinoids in medical cannabis cultivars using microbial consortia |
topic | Plant Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502174/ https://www.ncbi.nlm.nih.gov/pubmed/37719209 http://dx.doi.org/10.3389/fpls.2023.1219836 |
work_keys_str_mv | AT ahmedbulbul enhancedproductionofselectphytocannabinoidsinmedicalcannabiscultivarsusingmicrobialconsortia AT benesfrantisek enhancedproductionofselectphytocannabinoidsinmedicalcannabiscultivarsusingmicrobialconsortia AT hajslovajana enhancedproductionofselectphytocannabinoidsinmedicalcannabiscultivarsusingmicrobialconsortia AT fisarovalenka enhancedproductionofselectphytocannabinoidsinmedicalcannabiscultivarsusingmicrobialconsortia AT vosatkamiroslav enhancedproductionofselectphytocannabinoidsinmedicalcannabiscultivarsusingmicrobialconsortia AT hijrimohamed enhancedproductionofselectphytocannabinoidsinmedicalcannabiscultivarsusingmicrobialconsortia |